David Abraham
- TGF-β 1 suppresses IRF-1 expression in pulmonary fibroblasts and modulates its induction by IFN α and IFN γBy Patricia Leoni, Xu Shi-Wen, Carmel Stock, David Abraham, Andrew Nicholson, Toby Maher, Athol Wells, Elizabeth Renzoni and Gisela LindahlPatricia Leoni1Interstitial Lung Disease Unit, Royal Brompton Hospital, London, United KingdomXu Shi-Wen2Department of Rheumatology, Royal Free Hospital, London, United KingdomCarmel Stock1Interstitial Lung Disease Unit, Royal Brompton Hospital, London, United KingdomDavid Abraham2Department of Rheumatology, Royal Free Hospital, London, United KingdomAndrew Nicholson3Department of Histopathology, Royal Bropmton Hospital, London, United KingdomToby Maher1Interstitial Lung Disease Unit, Royal Brompton Hospital, London, United KingdomAthol Wells1Interstitial Lung Disease Unit, Royal Brompton Hospital, London, United KingdomElizabeth Renzoni1Interstitial Lung Disease Unit, Royal Brompton Hospital, London, United KingdomGisela Lindahl1Interstitial Lung Disease Unit, Royal Brompton Hospital, London, United Kingdom
- Identification of stable housekeeping genes for real-time PCR in human pulmonary fibroblastsBy Carmel Stock, Patricia Leoni, Xu Shi-Wen, David Abraham, Andrew Nicholson, Athol Wells, Elizabeth Renzoni and Gisela LindahlCarmel StockInterstitial Lung Disease Unit, Royal Brompton Hospital, London, United Kingdom Dept. Rheumatology, Royal Free Hospital, London, United Kingdom Dept Histopathology, Royal Brompton Hospital, London, United KingdomPatricia LeoniInterstitial Lung Disease Unit, Royal Brompton Hospital, London, United Kingdom Dept. Rheumatology, Royal Free Hospital, London, United Kingdom Dept Histopathology, Royal Brompton Hospital, London, United KingdomXu Shi-WenInterstitial Lung Disease Unit, Royal Brompton Hospital, London, United Kingdom Dept. Rheumatology, Royal Free Hospital, London, United Kingdom Dept Histopathology, Royal Brompton Hospital, London, United KingdomDavid AbrahamInterstitial Lung Disease Unit, Royal Brompton Hospital, London, United Kingdom Dept. Rheumatology, Royal Free Hospital, London, United Kingdom Dept Histopathology, Royal Brompton Hospital, London, United KingdomAndrew NicholsonInterstitial Lung Disease Unit, Royal Brompton Hospital, London, United Kingdom Dept. Rheumatology, Royal Free Hospital, London, United Kingdom Dept Histopathology, Royal Brompton Hospital, London, United KingdomAthol WellsInterstitial Lung Disease Unit, Royal Brompton Hospital, London, United Kingdom Dept. Rheumatology, Royal Free Hospital, London, United Kingdom Dept Histopathology, Royal Brompton Hospital, London, United KingdomElizabeth RenzoniInterstitial Lung Disease Unit, Royal Brompton Hospital, London, United Kingdom Dept. Rheumatology, Royal Free Hospital, London, United Kingdom Dept Histopathology, Royal Brompton Hospital, London, United KingdomGisela LindahlInterstitial Lung Disease Unit, Royal Brompton Hospital, London, United Kingdom Dept. Rheumatology, Royal Free Hospital, London, United Kingdom Dept Histopathology, Royal Brompton Hospital, London, United Kingdom
- LSC 2013 abstract - Hypoxia-inducible factor 1 alpha polymorphisms in relation to pulmonary involvement in systemic sclerosisBy Harpreet Lota, Carmel Stock, Hiroe Sato, Carmen Fonseca, Athol Wells, Christopher Denton, David Abraham, Gisela Lindahl and Elisabetta RenzoniHarpreet Lota1Interstitial Lung Disease Unit, Royal Brompton Hospital, London, United KingdomCarmel Stock1Interstitial Lung Disease Unit, Royal Brompton Hospital, London, United KingdomHiroe Sato1Interstitial Lung Disease Unit, Royal Brompton Hospital, London, United KingdomCarmen Fonseca2Centre for Rheumatology, Royal Free Hospital, London, United KingdomAthol Wells1Interstitial Lung Disease Unit, Royal Brompton Hospital, London, United KingdomChristopher Denton2Centre for Rheumatology, Royal Free Hospital, London, United KingdomDavid Abraham2Centre for Rheumatology, Royal Free Hospital, London, United KingdomGisela Lindahl1Interstitial Lung Disease Unit, Royal Brompton Hospital, London, United KingdomElisabetta Renzoni1Interstitial Lung Disease Unit, Royal Brompton Hospital, London, United Kingdom
- Comparison of current therapies against endothelin-induced growth in pulmonary smooth arterial muscle cells (PASMCs) derived from patients with pulmonary arterial hypertensionBy Jigisha Patel, David Abraham, Andrew Nelson, Adam Silverstein and Lucie ClappJigisha Patel1Medicine, UCL, London, United KingdomDavid Abraham1Medicine, UCL, London, United KingdomAndrew Nelson2Research Triangle Park, United Therapeutics Corporation, Durham, NC,Adam Silverstein2Research Triangle Park, United Therapeutics Corporation, Durham, NC,Lucie Clapp1Medicine, UCL, London, United Kingdom
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.